Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:GTHPNASDAQ:INBSNASDAQ:MHUAOTCMKTS:VYCO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGTHPGuided Therapeutics$0.27$0.17$0.06▼$0.30$20.95M0.1115,348 shsN/AINBSIntelligent Bio Solutions$1.86+1.6%$1.53$1.00▼$3.00$12.30M4.6563,789 shs508,618 shsMHUAMeihua International Medical Technologies$0.42-3.3%$0.39$0.25▼$1.47$13.96M0.79683,672 shs79,807 shsVYCOVycor Medical$0.13$0.13$0.04▼$0.50$4.42M-0.421,531 shsN/A12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGTHPGuided Therapeutics0.00%-5.18%+101.90%+219.49%+84.50%INBSIntelligent Bio Solutions0.00%+21.57%+17.72%+37.78%+1.09%MHUAMeihua International Medical Technologies0.00%-6.94%-25.99%+34.19%-53.26%VYCOVycor Medical0.00%0.00%+12.07%+103.94%+46.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGTHPGuided Therapeutics0.6334 of 5 stars0.03.00.00.02.31.70.0INBSIntelligent Bio Solutions0.3163 of 5 stars0.01.00.00.01.90.01.3MHUAMeihua International Medical Technologies1.1827 of 5 stars0.03.00.00.03.21.70.6VYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGTHPGuided Therapeutics 0.00N/AN/AN/AINBSIntelligent Bio Solutions 0.00N/AN/AN/AMHUAMeihua International Medical Technologies 0.00N/AN/AN/AVYCOVycor Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGTHPGuided Therapeutics$10K2,095.06N/AN/A($0.12) per share-2.21INBSIntelligent Bio Solutions$3.11M4.13N/AN/A$2.37 per share0.78MHUAMeihua International Medical Technologies$96.90M0.14$0.43 per share0.97$6.34 per share0.07VYCOVycor Medical$1.59M2.78N/AN/A($0.11) per share-1.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGTHPGuided Therapeutics-$2.42M-$0.05N/A∞N/AN/AN/A-197.32%8/12/2025 (Estimated)INBSIntelligent Bio Solutions-$10.16MN/A0.005.31N/A-319.85%-176.55%-93.89%9/17/2025 (Estimated)MHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/AVYCOVycor Medical-$110KN/A0.00∞N/A-6.86%N/A-11.44%8/11/2025 (Estimated)Latest VYCO, INBS, MHUA, and GTHP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025GTHPGuided TherapeuticsN/A-$0.01N/A-$0.01N/AN/A5/15/2025Q1 2025VYCOVycor MedicalN/A-$0.01N/A-$0.01N/A$0.44 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGTHPGuided TherapeuticsN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGTHPGuided TherapeuticsN/A0.140.03INBSIntelligent Bio SolutionsN/A1.120.97MHUAMeihua International Medical TechnologiesN/A5.265.21VYCOVycor MedicalN/A0.130.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGTHPGuided Therapeutics9.69%INBSIntelligent Bio Solutions32.97%MHUAMeihua International Medical Technologies1.17%VYCOVycor MedicalN/AInsider OwnershipCompanyInsider OwnershipGTHPGuided Therapeutics66.83%INBSIntelligent Bio Solutions1.54%MHUAMeihua International Medical Technologies66.56%VYCOVycor Medical7.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGTHPGuided Therapeutics578.91 million26.18 millionNot OptionableINBSIntelligent Bio Solutions106.91 million6.80 millionNot OptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableVYCOVycor Medical633.42 million31.07 millionNot OptionableVYCO, INBS, MHUA, and GTHP HeadlinesRecent News About These CompaniesVYCO Vycor Medical, Inc.May 31, 2025 | seekingalpha.comVycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 14, 2025 | finance.yahoo.comEQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 13, 2025 | markets.businessinsider.comMedical ethics articles from across Nature PortfolioOctober 22, 2024 | nature.comNBlueChew Review 2024January 17, 2024 | medicalnewstoday.comMWhat to know about bleeding hemorrhoidsDecember 19, 2023 | medicalnewstoday.comMCommon symptoms of depression: What to knowOctober 11, 2023 | medicalnewstoday.comMVycor Medical, Inc. (VYCO)January 7, 2023 | finance.yahoo.comMedical Review BoardNovember 1, 2022 | health.usnews.comMedical Scholars ProgramSeptember 12, 2022 | slu.eduSVycor Medical IncSeptember 8, 2022 | reuters.comMinnetronix commercializes its own product: a minimally invasive deep brain access portAugust 20, 2022 | medcitynews.comMViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMay 11, 2022 | nice.org.ukNVycor Medical Year to Date Total Returns (Daily)January 2, 2022 | ycharts.comYVycor Medical Inc (VYCO)December 17, 2021 | nasdaq.comThe journal of physical chemistry. BOctober 18, 2021 | medscape.comMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVYCO, INBS, MHUA, and GTHP Company DescriptionsGuided Therapeutics OTCMKTS:GTHP$0.27 0.00 (0.00%) As of 07/3/2025Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.Intelligent Bio Solutions NASDAQ:INBS$1.86 +0.03 (+1.64%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$1.77 -0.09 (-4.84%) As of 07/3/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Meihua International Medical Technologies NASDAQ:MHUA$0.42 -0.01 (-3.26%) Closing price 07/3/2025 01:48 PM EasternExtended Trading$0.42 0.00 (0.00%) As of 07/3/2025 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Vycor Medical OTCMKTS:VYCO$0.13 0.00 (0.00%) As of 07/3/2025Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
